The aging heart, myocardial fibrosis, and its relationship to circulating C-type natriuretic Peptide.
The aging heart, myocardial fibrosis, and its relationship to circulating C-type natriuretic Peptide.
复制标题
DOI:
10.1161/hypertensionaha.110.160796
复制
发表时间:
2011-02
期刊:
影响因子:
--
通讯作者:
Burnett JC Jr
中科院分区:
文献类型:
--
作者:
Sangaralingham SJ;Huntley BK;Martin FL;McKie PM;Bellavia D;Ichiki T;Harders GE;Chen HH;Burnett JC Jr
Myocardial aging is characterized by LV fibrosis leading to diastolic and systolic dysfunction. Studies have established the potent anti-fibrotic and anti-proliferative properties of C-type natriuretic peptide (CNP), however the relationship between circulating CNP, LV fibrosis and associated changes in LV function with natural aging are undefined. Accordingly, we characterized the relationship of plasma CNP with LV fibrosis and function in 2, 11 and 20 month old male Fischer rats. Further in vitro, we establish the anti-proliferative actions of CNP and the participation of the clearance receptor using adult human cardiac fibroblasts. Here we establish for the first time that a progressive decline in circulating CNP characterizes natural aging and is strongly associated with a reciprocal increase in LV fibrosis which precedes impairment of diastolic and systolic function. Additionally we demonstrate in cultured adult human cardiac fibroblasts that the direct anti-proliferative actions of high dose CNP may involve a non-cGMP pathway via the clearance receptor. Taken together these studies provide new insights into myocardial aging and the relationship to the anti-fibrotic and anti-proliferative peptide CNP.